ArriVent BioPharma, Inc. (AVBP)

Every official ArriVent BioPharma, Inc. filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

ArriVent BioPharma, Inc. documents

• ArriVent BioPharma, Inc. 10-K 2026AVBP 10-K 2026: annual report for fiscal 2026
• ArriVent BioPharma, Inc. 10-K 2025AVBP 10-K 2025: annual report for fiscal 2025
• ArriVent BioPharma, Inc. 10-K 2024AVBP 10-K 2024: annual report for fiscal 2024
• ArriVent BioPharma, Inc. 10-K 2023AVBP 10-K 2023: annual report for fiscal 2023
• ArriVent BioPharma, Inc. 10-K 2022AVBP 10-K 2022: annual report for fiscal 2022
• ArriVent BioPharma, Inc. 10-Q 2026AVBP 10-Q 2026: quarterly report for fiscal 2026
• ArriVent BioPharma, Inc. 10-Q 2025AVBP 10-Q 2025: quarterly report for fiscal 2025
• ArriVent BioPharma, Inc. 10-Q 2024AVBP 10-Q 2024: quarterly report for fiscal 2024
• ArriVent BioPharma, Inc. 10-Q 2023AVBP 10-Q 2023: quarterly report for fiscal 2023
• ArriVent BioPharma, Inc. 10-Q 2022AVBP 10-Q 2022: quarterly report for fiscal 2022
• ArriVent BioPharma, Inc. 8-K 2026AVBP 8-K 2026: current report for fiscal 2026
• ArriVent BioPharma, Inc. 8-K 2025AVBP 8-K 2025: current report for fiscal 2025
• ArriVent BioPharma, Inc. 8-K 2024AVBP 8-K 2024: current report for fiscal 2024
• ArriVent BioPharma, Inc. 8-K 2023AVBP 8-K 2023: current report for fiscal 2023
• ArriVent BioPharma, Inc. 8-K 2022AVBP 8-K 2022: current report for fiscal 2022
• ArriVent BioPharma, Inc. DEF 14A 2026AVBP DEF 14A 2026: proxy statement for fiscal 2026
• ArriVent BioPharma, Inc. DEF 14A 2025AVBP DEF 14A 2025: proxy statement for fiscal 2025
• ArriVent BioPharma, Inc. DEF 14A 2024AVBP DEF 14A 2024: proxy statement for fiscal 2024
• ArriVent BioPharma, Inc. DEF 14A 2023AVBP DEF 14A 2023: proxy statement for fiscal 2023
• ArriVent BioPharma, Inc. DEF 14A 2022AVBP DEF 14A 2022: proxy statement for fiscal 2022
• ArriVent BioPharma, Inc. Form 4 2026AVBP Form 4 2026: insider trading filing for fiscal 2026
• ArriVent BioPharma, Inc. Form 4 2025AVBP Form 4 2025: insider trading filing for fiscal 2025
• ArriVent BioPharma, Inc. Form 4 2024AVBP Form 4 2024: insider trading filing for fiscal 2024
• ArriVent BioPharma, Inc. Form 4 2023AVBP Form 4 2023: insider trading filing for fiscal 2023
• ArriVent BioPharma, Inc. Form 4 2022AVBP Form 4 2022: insider trading filing for fiscal 2022
• ArriVent BioPharma, Inc. S-1 2026AVBP S-1 2026: registration statement for fiscal 2026
• ArriVent BioPharma, Inc. S-1 2025AVBP S-1 2025: registration statement for fiscal 2025
• ArriVent BioPharma, Inc. S-1 2024AVBP S-1 2024: registration statement for fiscal 2024
• ArriVent BioPharma, Inc. S-1 2023AVBP S-1 2023: registration statement for fiscal 2023
• ArriVent BioPharma, Inc. S-1 2022AVBP S-1 2022: registration statement for fiscal 2022
• ArriVent BioPharma, Inc. 13F 2026AVBP 13F 2026: institutional holdings for fiscal 2026
• ArriVent BioPharma, Inc. 13F 2025AVBP 13F 2025: institutional holdings for fiscal 2025
• ArriVent BioPharma, Inc. 13F 2024AVBP 13F 2024: institutional holdings for fiscal 2024
• ArriVent BioPharma, Inc. 13F 2023AVBP 13F 2023: institutional holdings for fiscal 2023
• ArriVent BioPharma, Inc. 13F 2022AVBP 13F 2022: institutional holdings for fiscal 2022

More companies